Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCL8 | P10145 | 10/20 | 0.55 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.54 |
| ▸ | CTSB | P07858 | 2/20 | 0.54 |
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSH | P09668 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31247325 | 0.97 | CXCL8 (0.56) | CXCL8CAPN1CTSBDPP3MEN1 | |
| SCHEMBL30690108 | 0.97 | CAPN1 (0.59) | CXCL8CAPN1CTSBDPP3MEN1 | |
| SCHEMBL30690107 | 0.97 | CAPN1 (0.59) | CXCL8CAPN1CTSBDPP3MEN1 | |
| SCHEMBL31247348 | 0.96 | CAPN1 (0.57) | CXCL8CAPN1CTSBDPP3CTSL | |
| SCHEMBL30690106 | 0.96 | CXCL8 (0.52) | CXCL8CAPN1CTSBDPP3MEN1 | |
| SCHEMBL30690109 | 0.95 | CXCL8 (0.58) | CXCL8CAPN1CTSBDPP3CTSL | |
| SCHEMBL30690087 | 0.94 | CAPN1 (0.57) | CXCL8CAPN1CTSBDPP3 | |
| SCHEMBL31247502 | 0.94 | CXCL8 (0.54) | CXCL8CAPN1CTSBDPP3CTSL | |
| SCHEMBL30690070 | 0.93 | CAPN1 (0.57) | CXCL8CAPN1CTSBDPP3 | |
| SCHEMBL31247683 | 0.93 | CAPN1 (0.56) | CXCL8CAPN1CTSBDPP3CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024235070-A1 | PEPTIDE COMPOUND, COMPOSITION AND USE THEREOF | 杭州禾泰健宇生物科技有限公司 | 2024-11-21 | — | — | WO | disclosed |